Cancer, Evolution, ALife – May 27th 2020
Due to the COVID-19 pandemic, EVO-NANO is taking the step towards teleconferencing and moving our workshop (intended for April 2020) to an online platform. We are aiming to produce a …
Due to the COVID-19 pandemic, EVO-NANO is taking the step towards teleconferencing and moving our workshop (intended for April 2020) to an online platform. We are aiming to produce a …
Our research partners at ProChimia have recently been involved in a breakthrough paper where nanoparticles have selectively killed cancer cells in vitro without using any toxic anti-cancer agents. The paper, …
